Amphastar Pharmaceuticals: Peers

The FY2025 (Dec) proxy of Amphastar Pharmaceuticals names 16 peer companies for pay. Among Amphastar Pharmaceuticals and these peers, CEO pay was 7th highest of 10 and total shareholder return was 7th highest of 10.

7th highest of 10in Amphastar Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:

$5.3M$33.2M

7th highest of 10in Amphastar Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:

$13$306

Pay peer group, FY2025 (Dec) proxy

Exelixis
PTC Therapeutics
Halozyme Therapeutics
Supernus Pharmaceuticals
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Sarepta Therapeutics
Prestige Consumer Healthcare
Emergent BioSolutions
Acadia PharmaceuticalsNot disclosedNot disclosed
Ani PharmaceuticalsNot disclosedNot disclosed
Amicus Therapeutics, Inc.Not disclosedNot disclosed
Collegium Pharmaceuticals, Inc.Not disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Ironwood Pharmaceuticals, Inc.Not disclosedNot disclosed
Pacira BioSciencesNot disclosedNot disclosed
16 companies

PSU comparator group

The companies that relative total shareholder return is measured against for performance stock units.

NASDAQ Biotechnology Index (index)Not disclosedNot disclosed
1 company

Changes by year

FY2025 (Dec) proxy

  • AddedAcadia Pharmaceuticalspay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2024: (a) the removal of Amarin Corporation plc., Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc
  • AddedAmicus Therapeutics, Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2024: (a) the removal of Amarin Corporation plc., Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc
  • RemovedAmarin Corporation plc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2024: (a) the removal of Amarin Corporation plc., Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc
  • RemovedCoherus BioSciences, Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2024: (a) the removal of Amarin Corporation plc., Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc
  • RemovedEagle Pharmaceuticals, Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2024: (a) the removal of Amarin Corporation plc., Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc
  • RemovedIntercept Pharmaceuticals, Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2024: (a) the removal of Amarin Corporation plc., Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc

FY2024 (Dec) proxy

  • AddedAlnylam Pharmaceuticalspay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc
  • AddedExelixispay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc
  • AddedPrestige Consumer Healthcarepay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc
  • AddedSarepta Therapeuticspay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc
  • RemovedFibroGen Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc
  • RemovedTravere Therapeuticspay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc
  • RemovedVanda Pharmaceuticals, Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2023: (a) the removal of FibroGen Inc., Travere Therapeutics, Inc

FY2023 (Dec) proxy

  • AddedHalozyme Therapeuticspay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2022: (a) the removal of Lannett Company, Inc., as it no longer fit within the sales parameters used for determining our peer companies and (b) the addition of Halozyme Therapeutics, Inc., as the compensation committee determined that these companies better fit within the sales parameters used for determining our peer companies and were better benchmarks to our business
  • RemovedLannett Company, Inc.pay peer groupfollowing changes to the peer group from the peer group approved by the compensation committee in 2022: (a) the removal of Lannett Company, Inc., as it no longer fit within the sales parameters used for determining our peer companies and (b) the addition of Halozyme Therapeutics, Inc., as the compensation committee determined that these companies better fit within the sales parameters used for determining our peer companies and were better benchmarks to our business

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.